Orphanin FQ (OFQ, Nociceptin) is a recently discovered 17-amino acid neuropeptide that is structurally related to the opioid peptides but does not bind opioid receptors. OFQ has been proposed to act as an anti-opioid peptide, but its widespread sites of action in the brain suggest that it may have more general functions. Here we show that OFQ plays an important role in higher brain functions because it can act as an anxiolytic to attenuate the behavioral inhibition of animals acutely exposed to stressful͞anxiogenic environmental conditions. OFQ anxiolytic-like effects were consistent across several behavioral paradigms generating different types of anxiety states in animals (light-dark preference, elevated plus-maze, exploratory behavior of an unfamiliar environment, pharmacological anxiogenesis, operant conf lict) and were observed at low nonsedating doses (0.1-3 nmol, intracerebroventricular). Like conventional anxiolytics, OFQ interfered with regular sensorimotor function at high doses (>3 nmol). Our results show that an important role of OFQ is to act as an endogenous regulator of acute anxiety responses. OFQ, probably in concert with other major neuropeptides, exerts a modulatory role on the central integration of stressful stimuli and, thereby, may modulate anxiety states generated by acute stress.Orphanin FQ (OFQ, Nociceptin) is a 17-amino acid neuropeptide that is structurally related to the opioid peptides but does not act on , ␦, or opioid receptor subtypes (1, 2). OFQ selectively binds its own receptor (OFQR), which is also sequentially related to the opioid receptors, yet does not bind opioid ligands (3-8). The OFQR couples to G proteins to modulate second messenger systems and cell excitability (9-11). When delivered intracerebroventricularly (i.c.v.) in a large dose range (0.1-10 nmol), OFQ was found to block stress and opioid-mediated antinociception (12, 13), to stimulate feeding in satiated rats (14), and to increase or decrease, depending on dosage, locomotion (1, 15) or nociception (16, 17) in rodents. OFQ, its precursor, and OFQR are present in several brain regions involved in integration of the emotional components of fear and stress such as the amygdaloid complex, thalamic and hypothalamic regions, or central gray regions (1-8, 18, 19). This has led us to investigate whether OFQ might also have a role in higher brain functions and would control behavioral responses to stress that relate to anxiety states. To investigate this hypothesis, a battery of behavioral models of anxiety and fear (light-dark aversion, elevated plus-maze, exploratory behavior of an unfamiliar environment, pharmacological anxiogenesis, operant conflict) were used on mice and rats. In these assays, fear-like responses of a composite nature are generated by exposure to various stressful environmental conditions (20-27). These paradigms have been established for their sensitivity to conventional anxiolytic tranquilizers and anxiogenic compounds of various structural classes and mechanisms of action. They were pha...